The DOI matches its Crossref record; the references it cites are not checked yet.
From traditional to novel: a national cohort study on the predictive value of C-reactive protein–triglyceride–glucose-obesity composite parameters for cardiovascular disease
Abstract
Background: Cardiovascular disease (CVD) is the leading cause of mortality worldwide. The C-reactive protein–triglyceride–glucose (CTI) index captures metabolic inflammation and insulin resistance, while obesity indices reflect adiposity-related cardiometabolic risk. However, the predictive value of combining CTI with obesity indices for CVD remains unclear. Objectives: To examine the prognostic utility of CTI combined with established and novel obesity indicators for CVD, and to benchmark their predictive efficacy. Design: Nationally representative prospective cohort study. Methods: Using data from the China Health and Retirement Longitudinal Study (CHARLS), a nationally representative prospective cohort, 7847 adults aged 45 years and above without baseline CVD were enrolled. CTI was calculated from C-reactive protein, fasting blood glucose, and triglycerides (TG); each obesity index was combined with CTI to form composite parameters (CTI-body mass index (CTI-BMI), CTI-waist circumference (CTI-WC), CTI-waist-to-height ratio (CTI-WHtR), CTI-body roundness index (CTI-BRI), CTI-weight-adjusted waist index (CTI-WWI), CTI-Chinese visceral adiposity index (CTI-CVAI), CTI-a body shape index (CTI-ABSI)). We employed Cox proportional hazard models, restricted cubic spline analyses, Kaplan–Meier survival plots, ROC curve evaluations, and weighted quantile sum (WQS) regression to examine the links and prognostic utility of each metric with incident CVD across baseline and cumulative exposure tiers. Results: Over a 9-year follow-up period, 1938 new-onset CVD cases were documented. Following multivariable adjustment, each CTI-obesity composite metric showed a significant positive link to CVD risk ( p < 0.05). Moreover, all CTI‑obesity composite parameters showed stronger associations with CVD than CTI alone. CTI‑CVAI demonstrated the relatively best predictive accuracy among the evaluated indices, though absolute discriminatory ability remained modest (baseline area under the ROC curve (AUC): 0.596; cumulative AUC: 0.600). Trajectory clustering found that, versus the well-managed group, the poorly managed subgroup had 21%–71% higher CVD risk (max 71% for CTI-WC). WQS regression indicated that CRP and obesity indices (especially CVAI) were the major contributors in the mixed exposure; cumulative exposure WQS analysis showed that cumulative TG and cumulative obesity parameters contributed the most. Conclusion: CTI combined with obesity indices, particularly CTI-CVAI, was associated with modestly improved predictive ability for CVD risk compared with CTI alone. This parameter may offer incremental information for CVD risk stratification by integrating metabolic inflammation and visceral fat markers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists haven’t been fetched yet
Research works printed but not linked: 52
- 10.1093/qjmed/hcaf022 · DOI
- 10.1093/eurjpc/zwae281 · DOI · Paper page
- Hu S; National Center for Cardiovascular Diseases—the Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on cardiovascular health and diseases in China 2023: an updated summary. Biomed Environ Sci 2024; 37(9): 949–992.
- 10.1016/j.jacc.2025.08.060 · DOI
- 10.26599/1671-5411.2024.04.001 · doi:10.26599/1671-5411.2024.04.001
- 10.1177/03000605231164548 · DOI · Paper page
- 10.1089/met.2008.0034 · DOI · Paper page
- 10.1016/j.compbiomed.2026.111556 · DOI
- Yu Y, Yin J, Guo W, et al. Metabolic dysfunction and coronary plaque vulnerability: the predictive role of insulin resistance indices in cardiovascular outcomes. MedComm (2020) 2026; 7(2): e70636.
- 10.1016/j.jacc.2025.08.047 · DOI · Paper page
- 10.3389/fendo.2022.905266 · DOI · Paper page
- 10.1186/s12933-025-02960-w · DOI
- 10.1186/s12933-026-03109-z · DOI
- 10.1038/s42255-024-01046-3 · DOI
- 10.1111/obr.12991 · DOI · Paper page
- 10.1016/j.drudis.2021.11.001 · DOI · Paper page
- 10.1186/s12933-025-02972-6 · DOI
- 10.1093/ije/dys203 · DOI · Paper page
- 10.1136/bmj.39335.541782.AD · DOI · Paper page
- 10.1093/aje/kwz170 · doi:10.1093/aje/kwz170
- 10.1186/s12933-025-02980-6 · DOI
- 10.1186/s12933-024-02352-6 · DOI · Paper page
- 10.1186/s12933-026-03084-5 · DOI
- 10.1001/jama.2017.12126 · DOI · Paper page
- 10.1056/NEJMoa1614362 · DOI · Paper page
- 10.1016/j.metabol.2021.154766 · DOI · Paper page
- 10.1161/CIR.0000000000000973 · DOI · Paper page
- 10.2337/dc09-1825 · DOI · Paper page
- 10.2337/diacare.29.01.06.dc05-1805 · DOI · Paper page
- 10.1038/srep38214 · DOI · Paper page
- 10.4093/dmj.2022.0099 · DOI
- 10.1186/s12933-020-01095-4 · DOI · Paper page
- 10.1007/s11033-026-11509-3 · DOI
- 10.1161/01.CIR.91.5.1432 · DOI · Paper page
- Record RD, Johnson M, Lee S, et al. Aldosterone and insulin stimulate amiloride-sensitive sodium transport in A6 cells by additive mechanisms. Am J Physiol 1996; 271(4 Pt 1): C1079–C1084. · doi:10.1152/ajpcell.1996.271.4.c1079
- 10.1152/ajpcell.00372.2002 · DOI
- 10.1093/cvr/cvaa326 · DOI
- 10.2147/JIR.S539644 · DOI
- 10.1186/s12933-025-03063-2 · DOI
- 10.1186/s12933-026-03151-x · DOI
- 10.1210/jc.2010-0288 · DOI · Paper page
- 10.1186/s12933-023-01819-2 · DOI
- 10.1186/s12933-024-02290-3 · DOI
- 10.1186/s12944-025-02836-8 · DOI
- 10.1016/j.ijcard.2003.08.016 · DOI
- 10.1186/s12933-024-02571-x · DOI
- 10.1186/s12933-025-02835-0 · DOI
- 10.1186/s12933-025-02869-4 · DOI
- 10.1186/s12933-026-03132-0 · DOI
- 10.1186/s12933-025-03065-0 · DOI
- 10.1016/j.numecd.2026.104609 · DOI
- 10.1002/dmrr.70109 · DOI
Metadata
- Authors
- Zhao, M., Wang, X., Zhang, X., Yan, Y., Li, Z., Lu, F., & Li, Q.
- Venue
- Therapeutic Advances in Endocrinology and Metabolism
- Publisher
- SAGE Publications
- Published
- 2026-03
- Volume
- 17
- ISSN
- 2042-0188
- 2042-0196
- Cited by
- 0
- Language
- en
- Licence
- creativecommons.org/licenses/by-nc/4.0/ (vor)
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Funders
- Objective Research on Four Diagnostic Methods of Traditional Chinese Medicine in Coronary Heart Disease with Blood Stasis Syndrome (BRWEP2024Z014170101)
- Study on Evaluation Technology System of Herb-Drug Interaction Between Traditional Chinese Medicines and Western Medicines
- Taking Compound Prescriptions for Activating Blood Circulation to Remove Blood Stasis Combined with Antiplatelet Drugs as an Example (BRWEP2024Z014170102)
- Evidence-Based Evaluation and Translational Application of Warming Yang and Promoting Blood Circulation Therapy for Chronic Arrhythmia (BRWEP2024Z014170107)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: From traditional to novel: a national cohort study on the predictive value of C-reactive protein–triglyceride–glucose-obesity composite parameters for cardiovascular disease. https://app.cochat.ai/papers/10.1177/20420188261471668
- The paper
- Zhao, M., Wang, X., Zhang, X., Yan, Y., Li, Z., Lu, F., & Li, Q. (2026). From traditional to novel: a national cohort study on the predictive value of C-reactive protein–triglyceride–glucose-obesity composite parameters for cardiovascular disease. Therapeutic Advances in Endocrinology and Metabolism. https://doi.org/10.1177/20420188261471668
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.